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ARTICLE
Allomorphy as a mechanism of post-translational
control of enzyme activity
Henry P. Wood1,4, F. Aaron Cruz-Navarrete 1,4✉, Nicola J. Baxter1,2,4, Clare R. Trevitt1, Angus J. Robertson1,3,
Samuel R. Dix 1, Andrea M. Hounslow1, Matthew J. Cliff 2 & Jonathan P. Waltho 1,2✉
Enzyme regulation is vital for metabolic adaptability in living systems. Fine control of enzyme
activity is often delivered through post-translational mechanisms, such as allostery or allo-
kairy. β-phosphoglucomutase (βPGM) from Lactococcus lactis is a phosphoryl transfer enzyme
required for complete catabolism of trehalose and maltose, through the isomerisation of β-
glucose 1-phosphate to glucose 6-phosphate via β-glucose 1,6-bisphosphate. Surprisingly for
a gatekeeper of glycolysis, no fine control mechanism of βPGM has yet been reported.
Herein, we describe allomorphy, a post-translational control mechanism of enzyme activity.
In βPGM, isomerisation of the K145-P146 peptide bond results in the population of two
conformers that have different activities owing to repositioning of the K145 sidechain. In vivo
phosphorylating agents, such as fructose 1,6-bisphosphate, generate phosphorylated forms of
both conformers, leading to a lag phase in activity until the more active phosphorylated
conformer dominates. In contrast, the reaction intermediate β-glucose 1,6-bisphosphate,
whose concentration depends on the β-glucose 1-phosphate concentration, couples the
conformational switch and the phosphorylation step, resulting in the rapid generation of the
more active phosphorylated conformer. In enabling different behaviours for different allo-
morphic activators, allomorphy allows an organism to maximise its responsiveness to
environmental changes while minimising the diversion of valuable metabolites.
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nzyme regulation is vital in maintaining the balance of
catabolism and anabolism in living systems1–3. Enzyme
activity is subject to precise control, sometimes involving
manifold layers of regulation, and failure often results in meta-
bolic disorders and disease4,5. Regulatory mechanisms are divided
into two broad categories: those relating to the control of enzyme
concentration (coarse control) and those that modulate enzyme
activity (fine control). In coarse control, concentration is deter-
mined by transcriptional modulation of gene expression and the
balance between the rates of translation and degradation, with
additional contributions from maturation, cellular compartmen-
talisation and local co-clustering6–9. Coarse control occurs on
relatively long timescales (hours to days). In fine control, a diverse
group of regulatory mechanisms act to modulate enzyme activity
over much shorter timescales (<second to minutes). This group
includes the binding of regulatory molecules and reversible
covalent modification10,11, and often involves allosteric modula-
tion, where an effector, acting somewhere other than the active
site, stabilises forms of the enzyme with a reduced or enhanced
activity2,12–14. Alternatively, allokairy is a fine control mechan-
ism, where the activity of a monomeric enzyme is modulated by
the near-equivalence of the conformational exchange rate and the
catalytic rate in a substrate concentration-dependent manner15,16.
Precise enzyme regulation allows organisms to be responsive to
environmental changes and to exploit multiple energy sources.
Lactococcus lactis (L. lactis) is a Gram-positive bacterium that has
worldwide usage in the manufacture of fermented dairy products
and in the commercial production of lactic acid17. It can grow
on a variety of carbohydrate media including trehalose and
maltose18–20. Trehalose is transported into L. lactis by the
phosphoenolpyruvate-dependent phosphotransferase system,
yielding trehalose 6-phosphate (T6P), which is phosphorolysed
by Pi-dependent trehalose 6-phosphate phosphorylase to β-
glucose 1-phosphate (βG1P) and glucose 6-phosphate (G6P)21
(Supplementary Fig. 1). In contrast, maltose enters cells by the
ATP-dependent permease system and is phosphorolysed by
the action of Pi-dependent maltose phosphorylase to βG1P and
glucose22. Glucose is subsequently phosphorylated to G6P by
glucokinase and enters glycolysis via fructose 1,6-bisphosphate
(F16BP). For complete catabolism of both trehalose and
maltose, the isomerisation of βG1P to G6P is catalysed by β-
phosphoglucomutase (βPGM, EC 5.4.2.6, 25 kDa). βPGM-
deficient L. lactis is unable to grow or has impaired growth,
when the sole carbon source is trehalose or maltose, respec-
tively23. With maltose, βG1P accumulates intracellularly and is
excreted into the growth medium. Correspondingly, both Pi-
dependent trehalose 6-phosphate phosphorylase and Pi-depen-
dent maltose phosphorylase (Supplementary Fig. 1) operate in the
reverse sense to their physiological roles in wild-type L. lactis,
resulting in βG1P being combined with G6P to form T6P or
polymerised to form amylose (α(1–4)-linked glucose units). In
trehalose and maltose metabolism, therefore, βPGM acts as the
gatekeeper to and from glycolysis, and is expected to be subject to
tight regulation. In terms of coarse control, transcription of the
βPGM gene (pgmB), which is located in the tre operon, is subject
to negative transcriptional control by glucose and lactose19. When
L. lactis switches from metabolising glucose to metabolising
maltose (or by implication, trehalose), there is a significant rise in
the specific activity of βPGM over a period of several hours.
However, no fine control mechanism has yet been identified at
basal levels of βPGM, which would allow the cell to compete
more successfully during a transition between carbohydrate
sources.
βPGM is a monomeric magnesium-dependent phosphoryl
transfer enzyme of the haloacid dehalogenase (HAD) super-
family24–31. The active site is located in the cleft between the α/β
core domain (M1–D15, S88–K216) and the α-helical cap domain
(T16–V87), with closure of the cleft through domain reorienta-
tion occurring during catalysis. Two phosphate group binding
sites are present, a proximal site adjacent to the carboxylate
nucleophile and the catalytic Mg2+ ion, and a distal site located
~8 Å away in the closed enzyme29. During steady-state catalysis,
βG1P binds to phosphorylated βPGM (βPGMP, phosphorylated
on D8) and forms β-glucose 1,6-bisphosphate (βG16BP). Release
to solution and subsequent rebinding of βG16BP in the alternate
orientation32 leads to the formation of G6P and the regeneration
of βPGMP (Fig. 1). In vitro, a phosphorylating (priming) agent is
required to initiate the catalytic cycle since the half-life of βPGMP
is ~30 s28. In vivo, potential candidates for this agent include
F16BP, βG1P, G6P, α-glucose 1,6-bisphosphate (αG16BP) and
acetyl phosphate (AcP), as well as the reaction intermediate,
βG16BP. However, only βG16BP allows βPGM to reach its
maximum catalytic rate, and a significant lag phase is observed in
the reaction with αG16BP as the phosphorylating agent28, until
the βG16BP concentration greatly exceeds its resting concentra-
tion in the cell. In the current kinetic model for βPGM catalysis,
αG16BP is also required to act as a very strong inhibitor of
βPGM. αG16BP is a close structural analogue of βG16BP25, but
very similar kinetic behaviour is observed when AcP is used as the
phosphorylating agent31, suggesting that other factors are con-
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Fig. 1 βPGM catalytic cycle. βPGM reaction scheme for the enzymatic conversion of βG1P to G6P via a βG16BP intermediate. The phosphoryl transfer
reaction between phospho-enzyme (βPGMP, phosphorylated at residue D8) and βG1P is illustrated with the transferring phosphate (blue) in the proximal
site and the 1-phosphate (red) of βG1P in the distal site. The phosphoryl transfer reaction between βPGM and βG16BP is shown with the transferring
phosphate (red) in the proximal site and the 6-phosphate (blue) of βG16BP in the distal site.
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tributing to post-translational control of βPGM. Here we show,
through combined use of NMR spectroscopy, X-ray crystal-
lography, site-directed mutagenesis and kinetic assays, that a
regulatory mechanism is operating in βPGM, which we have
termed allomorphy to illustrate its relationship to and distinction
from allostery and allokairy. In the substrate-free enzyme, the
isomerisation of proline 146 results in the near-equal population
of two conformers that have different activities. Alternative
phosphorylating agents such as F16BP and AcP generate phos-
phorylated forms of both conformers, resulting in a lag phase in
βPGM activity until the more active phosphorylated conformer
dominates. In contrast, the βG16BP reaction intermediate is able
to couple the conformational switch and the phosphorylation
step, resulting in the rapid generation of the more active phos-
phorylated species. This allows the βG16BP concentration to
effectively act as a surrogate of the βG1P concentration and
modulate the activity of βPGM according to the carbohydrate
source available to L. lactis.
Results
βPGMWT exchanges slowly between two stable conformations.
The observation of a lag phase when using either αG16BP or
AcP28,31 as the phosphorylating agent implies that the target of
phosphorylation, the substrate-free enzyme, has a role in post-
translational control. Hence, the solution properties of substrate-
free wild-type βPGM (βPGMWT) were investigated using NMR
spectroscopy. In the previous backbone resonance assignment of
βPGMWT (BMRB 723526) performed in standard NMR buffer
(50 mMK+ HEPES (pH 7.2), 5 mM MgCl2, 2 mM NaN3, 10% (v/
v) 2H2O and 1mM trimethylsilyl propanoic acid (TSP)) con-
taining 10 mM NH4F, two features were apparent during the
analysis: (1) peaks of 30 active site residues were missing from the
spectra owing to line-broadening resulting from conformational
exchange on the millisecond timescale and (2) a large number of
unassigned 1HN, 15N, 13Cα, 13Cβ and 13C’ resonances were pre-
sent with a low intensity. To test whether HEPES or NH4F were
contributing to the millisecond conformational exchange, spectra
were recorded in tris buffer (50 mM tris (pH 7.2), 5 mMMgCl2, 2
mM NaN3, 10% (v/v) 2H2O and 1mM TSP) and mixtures of
HEPES and tris buffers in order to transfer the assignment
between conditions33. It was noticed that the inclusion of 5 mM
tris in the standard NMR buffer increased the intensity of the
unassigned resonances significantly and therefore all observable
resonances in the spectra were re-assigned using standard triple
resonance TROSY-based methodology34. Excluding the ten pro-
line residues and the N-terminal methionine, the backbone
resonances of 193 out of a total of 210 residues (92%) were
assigned. Seventeen residues located in the vicinity of the active
site remained unassigned (L9, D10, G11, R38, L44, K45, G46, S48,
R49, E50, D51, S52, L53, K117, N118, D170 and S171). Notably,
102 of the assigned residues displayed pairs of resonances in the
1H15N-TROSY spectrum (Fig. 2a, Supplementary Fig. 2a), con-
sistent with the population of two βPGMWT conformers (70%
conformer A, BMRB 28095 and 30% conformer B, BMRB 28096).
A further five residues (K145, A147, D149, I150 and Q176) have
assignments in conformer A, but are missing assignments in
conformer B, owing to some differential millisecond conforma-
tional exchange occurring in the two species. The βPGMWT
conformers are present in the spectra as a result of slow con-
formational exchange rather than as chemically distinct species,
as the addition of 3 mM BeCl2 and 10 mM NH4F to the βPGMWT
sample induced the population of a single βPGMWT:BeF3 com-
plex (an analogue of phosphorylated conformer A; BMRB
1785135) (Supplementary Fig. 3a). The exchange between con-
former A and conformer B is on the multi-second timescale, with
kex ≤ 1.0 s−1 from ZZ-exchange measurements. Differences in
chemical shift between the two conformers (Supplementary
Fig. 4a) indicate that the regions of βPGMWT involved in the
multi-second conformational exchange process are located pri-
marily in the core domain and comprise the D137–A147 loop, the
β-strands (K109–A113 and D133–A136) at the outer edge of the
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Fig. 2 Effect of different phosphorylating agents on βPGM. a, b Overlays
of a section of 1H15N-TROSY spectra highlighting the behaviour of residue
A113. a βPGMWT (black) populates conformer A and conformer B in slow
exchange. βPGMWT supplemented with F16BP (pink) populates
phosphorylated conformer A (AP) as the dominant species, phosphorylated
conformer B (BP) and a βPGMWT:F16BP species (A:F16BP). βPGMWT
supplemented with βG16BP (green) populates an A:βG16BP complex.
b βPGMP146A (black) populates one conformer (conformer B). βPGMP146A
supplemented with F16BP (pink) populates conformer B and BP. βPGMP146A
supplemented with βG16BP (green) populates a AP:G6P complex and a
B:βG16BP complex. Peaks indicated by grey asterisks correspond to the
βPGMWT:BeF3 complex (grey; δN= 133.5 ppm; BMRB 17851
35), which is an
analogue of AP, and the Mg2+-saturated βPGMD10N:βG16BP complex (grey;
δN= 133.8 ppm; BMRB 27174
31), which is a mimic of the A:βG16BP
complex, and are shown for comparison.
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β-sheet and the I152–S163 and Q172–A183 α- and 310-helical
regions (Fig. 3). Predicted random coil index order parameters
(RCI-S2)36 show a decrease in value for conformer B in two
regions (G32–R38 in the cap domain and D133–K145 in the core
domain) (Supplementary Fig. 5a), which indicates increased
conformational flexibility compared with conformer A.
Influence of physiological factors on the conformational
exchange. An investigation of factors that could potentially affect
the population distribution of conformer A and conformer B was
performed using 1H15N-TROSY spectra of βPGMWT recorded
under different conditions of temperature, pH, hydrostatic pres-
sure, MgCl2 (0–100 mM), NaCl (0–200 mM), K+ HEPES buffer
(0–200 mM) and βPGMWT concentration (0.1–1.2 mM). All of
these perturbations had little or no effect, apart from the addition
of either MgCl2 (100 mM) or NaCl (200 mM) to standard NMR
buffer, which shifted the population of βPGMWT primarily to
conformer A (Supplementary Fig. 6a–d). Buffer exchange into
deionised water resulted in conformer B being the dominant
population. However, both conformer A and conformer B
remained populated when Mg2+ was removed from the NMR
buffer solution, showing that the multi-second conformational
exchange is not simply a result of incomplete saturation of the
catalytic Mg2+-binding site. These observations indicate that
chloride anions perturb the population distribution.
The inorganic ionic composition of L. lactis cytoplasm (~2 mM
Mg2+, ~50 mM Na+, ~400 mMK+, ~50 mM Cl−)37 overlaps
with the concentration ranges tested, where the population
distribution between conformer A and conformer B remained
unaffected. Therefore, it is expected that both conformer A and
conformer B are populated in cytoplasm. However, the
intracellular milieu is a complex mix of metabolites that could
influence this equilibrium. This environment was mimicked
through the use of bovine skimmed milk, a medium in which L.
lactis thrives within the dairy industry. It is anticipated that the
organic components in milk will also be present in cytoplasm.
Moreover, the inorganic ionic composition (~5 mM Mg2+, ~24
mM Na+, ~38 mMK+, ~28 mM Cl−)38 is similar to cytoplasm
(except for K+, which has no effect on the equilibrium between
conformer A and conformer B), so any effects will be owing to the
influence of metabolites. βPGMWT was diluted fivefold into fresh
skimmed milk, which had been filtered to remove species with a
molecular weight larger than 10 kDa. The 1H15N-TROSY
spectrum revealed that both conformer A and conformer B were
populated with a similar ratio (60% conformer A and 40%
conformer B) to βPGMWT recorded in standard NMR buffer
(Supplementary Figs. 2c, 7a). However, minor chemical shift
changes in the active site loops and the sharpening of some peaks
that were line-broadened under standard conditions indicated
that one of the milk components was binding in the vicinity of the
active site. The two dominant organic components of the filtered
milk were lactose and citrate (Supplementary Fig. 2d). Titration
of lactose into βPGMWT had no effect on the 1H15N-TROSY
spectrum, whereas titration of citrate led to equivalent chemical
shift changes and sharpening of line-broadened peaks to those
observed in milk. Similar effects were observed in both conformer
A and conformer B. Hence, βPGMWT was crystallised in the
presence of citrate and the structure was determined to 2.1 Å
resolution (PDB 6YDM; Supplementary Fig. 8a–c, Supplementary
Table 1). Two chains are present in the crystallographic
asymmetric unit, one of which has citrate and acetate bound,
whilst the other has tris and acetate bound. Citrate is coordinated
in the active site by residues T16, H20, V47–R49 and A115–K117
and mimics substrate binding to some extent. Both monomers
share a similar fold and overlay closely with a previously reported
substrate-free βPGMWT structure (PDB 2WHE29; non-H atom
RMSDs of 0.56 Å and 0.95 Å). Although only one of the two
conformers observed in solution is represented in the crystal, the
NMR experiments show that both conformer A and conformer B
remain well-populated under physiological conditions.
The conformational exchange involves cis–trans proline iso-
merisation. Exchange phenomena on multi-second timescales in
proteins are often a consequence of cis–trans isomerisation of
Xaa-Pro peptide bonds39,40. The largest differences in chemical
shift between conformer A and conformer B are observed for
residues in a loop (D137–A147) containing two proline residues
(P138 and P146) (Supplementary Fig. 4a). From the crystal
structures of the substrate-free form of the enzyme (PDB 6YDL
(Supplementary Table 1) determined to 1.5 Å resolution, which
compares closely with PDB 2WHE29 (non-H atom RMSD= 0.53
Å) and PDB 1ZOL25 (non-H atom RMSD= 0.65 Å)), nine trans
Xaa-Pro peptide bonds are present in βPGMWT, whereas the
K145–P146 peptide bond adopts a cis conformation. Proline
residues with cis peptide bonds have 13Cβ nuclei that resonate
2.0–2.5 ppm downfield from those with trans peptide bonds41
and therefore the isomerisation state of the Xaa-Pro peptide
bonds for βPGMWT in solution was investigated. All but one of
the assigned proline residues in conformer A and conformer B
possess 13Cβ chemical shifts in the range 30.4–31.9 ppm con-
sistent with the population of trans Xaa-Pro peptide bonds
(Supplementary Fig. 5b). In contrast, the 13Cβ chemical shift for
P146 (34.7 ppm) corroborates the presence of a cis K145–P146
peptide bond in solution for conformer A. However for con-
former B, the absence of proline 13Cβ resonances for P146 and
P148, owing to millisecond conformational exchange in the
K145–I150 region, precluded an identification of the isomerisa-
tion state for these proline residues using NMR methods.
To explore whether proline isomerisation at the K145–P146
peptide bond is the source of the multi-second conformational
exchange in βPGMWT, the βPGM variant P146A (βPGMP146A)
was prepared and the solution properties of the substrate-free
form were investigated. A 1H15N-TROSY spectrum shows that
only a single species is present (Fig. 2b, Supplementary Fig. 2b)
Core domain
Cap domain
Hinge
Fig. 3 Exchange behaviour in βPGMWT. Crystal structure of βPGMWT (PDB
2WHE29) showing residues of βPGMWT undergoing conformational
exchange on different timescales. Residues that populate two
conformations in slow exchange are coloured in shades of blue according to
chemical shift differences between conformer A and conformer B, with the
intensity of colour and thickness of the backbone corresponding to larger
values. Residues in conformer A and conformer B with missing backbone
amide peaks in the 1H15N-TROSY spectrum of βPGMWT are coloured black,
whereas missing backbone amide peaks in conformer B only are coloured
purple. The amide 1H15N coherences are likely broadened beyond detection
owing to intermediate exchange on the millisecond timescale. The catalytic
Mg2+ ion is indicated as a green sphere.
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and 194 out of a total of 211 residues (92%) were assigned using
standard TROSY-based methodology (BMRB 2792042). The same
seventeen residues as βPGMWT remain unassigned owing to
millisecond conformational exchange. The chemical shifts of
βPGMP146A were compared with those of conformer A and
conformer B of βPGMWT (Supplementary Fig. 4b, c). Although
the largest perturbations relate to the mutation site (together with
an associated propagation of effects through the P148–V158 and
S171–G182 α-helices), additional significant and widespread
chemical shift differences are present between conformer A and
βPGMP146A, especially in the D137–A147 loop. In contrast, much
smaller chemical shift changes are observed between conformer B
and βPGMP146A, indicating that the solution conformations for
these species are closely similar. However, although the
K145–A146 peptide bond in βPGMP146A is likely to adopt a
trans conformation as the dominant population, the isomerisa-
tion state remains ambiguous using NMR methods. Therefore,
βPGMP146A was crystallised and the structure was determined to
2.0 Å resolution (PDB 6YDK; Supplementary Table 1). The cap
and the core domains of the crystal structure superimpose closely
with those of βPGMWT (non-H atom RMSD= 0.33 Å, PDB
2WHE29; non-H atom RMSD= 0.48 Å, PDB 6YDL; non-H atom
RMSD= 0.51 Å, PDB 1ZOL25). The D137–A147 loop exhibits
elevated temperature factors, consistent with the lower predicted
RCI-S2 values derived from NMR chemical shifts (Supplementary
Fig. 5c). The electron density is best fit by the trans conformation
of the K145–A146 peptide bond (ω dihedral angle=−177°)
(Fig. 4a, c). In comparison with βPGMWT, the D137–A147 loop
adopts a different conformation, although both a 310-helix
(D137–V141) and a β-turn hydrogen bond (A147HN–S144CO)
are retained. These perturbations in structure are consistent with
the chemical shift changes observed between conformer A and
βPGMP146A and support the βPGMP146A structure being a close
model of conformer B.
The most pronounced consequence of the change in
isomerisation state of the K145–A146 peptide bond is the failure
of the K145 sidechain in βPGMP146A to engage in the active site
(Fig. 4a). Instead, this sidechain is positioned in the open
cleft between the cap and core domains, and is exposed to solvent.
In βPGMWT, the ε-amino group of K145 is coordinated by
the carbonyl oxygen atom of A113, the carboxylate sidechain of
E169, and a water molecule that is replaced in the transition
state analogue (TSA) complex (PDB 2WF529) by a fluoride ion
that mimics an oxygen atom of the transferring phosphoryl
group. An electrostatic relationship also exists between the
ε-amino group and the carboxylate group of D8. In βPGMP146A,
A147a c
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Fig. 4 Conformational plasticity of the active site of βPGM. a, b Active sites of βPGMWT (as conformer A) and βPGMP146A superposed on the core
domain. a Selected residues are shown as sticks for the crystal structures of βPGMWT (grey carbon atoms; PDB 6YDL) and βPGMP146A (dark green carbon
atoms; PDB 6YDK). In βPGMWT, a cis K145–P146 peptide bond allows coordination of the K145 sidechain by E169 and A113, whereas in βPGMP146A a trans
K146-A146 peptide bond changes significantly the backbone conformation of the D137–A147 loop, which precludes active site engagement of the
K145 sidechain. The catalytic Mg2+ ion is drawn as a green sphere, black dashes indicate metal ion coordination and orange dashes show probable
hydrogen bonds. b Selected residues, the MgF3
– moiety and G6P are shown as sticks for the crystal structures of the βPGMWT:MgF3:G6P TSA complex
(grey carbon atoms; PDB 2WF529) and the βPGMP146A:MgF3:G6P TSA complex (dark green carbon atoms; PDB 6YDJ). βPGMWT maintains the cis
K145–P146 peptide bond, whereas βPGMP146A changes the isomerisation state of the K145–A146 peptide bond from a trans conformation in the substrate-
free enzyme to a cis conformation in the transition state. c, d Omit maps generated by refinement in the absence of residues S144–P148 in βPGMP146A.
c The S144–P148 segment, containing a trans K145–A146 peptide bond, with positive difference density (Fo–Fc; green mesh contoured at +2.5σ) in
substrate-free βPGMP146A. d The S144–P148 segment, containing a cis K145–A146 peptide bond, with positive difference density (Fo–Fc; green mesh
contoured at +2.5σ) in the βPGMP146A:MgF3:G6P TSA complex.
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the position of the missing ε-amino group of K145 and its
βPGMWT hydrogen bonding are satisfied by a water molecule.
The predicted RCI-S2 order parameters for βPGMP146A and
βPGMWT (Supplementary Fig. 5a, c) share similar profiles apart
from the D137–A147 loop region, where the RCI-S2 values for
βPGMP146A indicate increased dynamic properties that broadly
mirror those of conformer B in βPGMWT. Together, these data
reveal that βPGMP146A reflects the properties of conformer B, and
link the chemical shift and RCI-S2 differences between con-
formers to the isomerisation state of the K145-X146 peptide
bond. Thus, the multi-second exchange between conformer A
and conformer B in solution involves cis–trans proline isomer-
isation of the K145–P146 peptide bond.
βPGMWT lag phase depends on the phosphorylating agent. To
ensure that the extent of the lag phase observed previously with
AcP is not a method dependent observation31, the effect of dif-
ferent phosphorylating agents on the mutase activity of βPGMWT
was investigated by monitoring the conversion of 50 µM βG1P to
G6P with either F16BP (1 mM), AcP (8 mM) or βG16BP (10 µM)
present as phosphorylating agents, using the standard glucose 6-
phosphate dehydrogenase coupled assay28. Despite the crucial
involvement of βG16BP as the reaction intermediate in the
catalytic cycle, its concentration in the cell can vary markedly and
is dependent upon the concentration of βG1P. Therefore, F16BP
is the most likely phosphorylating agent of βPGMWT in vivo
when L. lactis is growing on glucose-rich media (~50 mM
F16BP17 versus Km ~100 µM25). AcP is also a potential activator
in vivo, as although it is present at lower concentrations (1–3 mM
in Escherichia coli (E. coli)43,44 versus Km ~800 µM25), it is
inherently a much faster phosphorylating agent. In the coupled
assay experiments with βPGMWT (Fig. 5a), when either F16BP or
AcP was used as the phosphorylating agent, their progression
curves display significant lag phases. The lag is considerably more
pronounced in the F16BP experiment, and consequently the
maximum rate of βG1P to G6P conversion is not achieved before
the substrate is exhausted. When βG16BP was used as the
phosphorylating agent the kinetic profile shows a linear, fast
initial rate. Consequently, initial rate measurements were made at
several βG1P and βG16BP concentrations (10–700 µM and
0.4–100 µM, respectively) and were globally fitted to an equation
derived for a ping–pong mechanism with βG1P inhibition28.
Accurate fits were obtained at βG16BP concentrations up to 10
µM, as above this concentration the model no longer describes
the data. At elevated βG16BP concentrations, the back reaction
from βG16BP to βG1P becomes significant, and the free βG16BP
concentration is attenuated owing to a multimeric interaction
between βG16BP and Mg2+ ions31. Accordingly, the data above
10 µM βG16BP were omitted from the fitting. This analysis
yielded values for kcat of 382 ± 12 s−1, Km (βG1P) of 91 ± 4 µM,
Km (βG16BP) of 8.5 ± 0.3 µM and Ki (βG1P) of 1510 ± 100 µM
(Supplementary Fig. 9a). These values are all higher than those
previously reported25,28 for βPGMWT owing to the extension of
the analysis to higher βG1P and Mg2+ concentrations.
βPGM catalysis utilises a cis K145-X146 peptide bond. To
assess whether βPGM is active as conformer B, the effect of dif-
ferent phosphorylating agents on the mutase activity of
βPGMP146A was investigated by monitoring the conversion of 50
µM βG1P to G6P with either F16BP (1 mM), AcP (8 mM) or
βG16BP (10 µM) present as phosphorylating agents using the
standard glucose 6-phosphate dehydrogenase coupled assay. As
for βPGMWT, the kinetic profiles for βPGMP146A display sig-
nificant lag phases with F16BP and AcP, whereas the progression
curve with βG16BP shows a linear, fast initial rate (Fig. 5b).
Consequently, initial rate measurements were made at several
βG1P and βG16BP concentrations (5–500 µM and 2–100 µM,
respectively) and were globally fit to the equation used for
βPGMWT above. For βPGMP146A, the fitting yielded values for kcat
of 19.2 ± 0.2 s−1, Km (βG1P) of 157 ± 3 µM, Km (βG16BP) of 175
± 3 µM and Ki (βG1P) of 933 ± 32 µM (Supplementary Fig. 9b). In
addition, the equilibration of βG1P and G6P for both βPGMWT
and βPGMP146A was monitored by 31P NMR spectroscopy using
AcP as a phosphorylating agent (Supplementary Fig. 9c, d)31. The
time courses show a similar overall profile together with the
presence of the lag phase and subsequent fitting of the linear
segments yielded a kobs of 70 ± 30 s−1 for βPGMWT and a kobs of
1.1 ± 0.2 s−1 for βPGMP146A. The variation between the kinetic
parameters derived using the two methods is caused by inhibition
resulting from different levels of phosphate-containing species
present in the assays. However, the data clearly demonstrate that
βPGMP146A is active, with a ~20-fold reduction in kcat, a ~21-fold
increase in Km for βG16BP and a similar Km and Ki for βG1P,
when compared with βPGMWT.
The mechanism of βPGMP146A catalytic activity was
explored by preparing a TSA complex containing MgF3– and
G6P29,45 and the resulting βPGMP146A:MgF3:G6P TSA com-
plex was investigated using NMR spectroscopy. The observed
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Fig. 5 Kinetic profiles of βPGM activity. a, b Reaction kinetics for the
conversion of βG1P to G6P catalysed by βPGMWT and βPGMP146A. The rate
of G6P production was measured indirectly using a glucose 6-phosphate
dehydrogenase coupled assay, in which G6P is oxidised and concomitant
NAD+ reduction is monitored by the increase in absorbance at 340 nm.
Reaction catalysed by either a βPGMWT or b βPGMP146A in standard kinetic
buffer using either F16BP (circles), AcP (squares) or βG16BP (diamonds) as
a phosphorylating agent. For clarity, between 100 and 8% of the data points
are included in the kinetic profiles. Following βG1P substrate depletion, the
kinetic profiles show an apparent increase in G6P concentration, which
results from: (1) the concentration of the reaction ingredients through
evaporation from the assay plate wells and (2) for the reactions recorded
using βG16BP, the enzyme-dependent conversion of remaining βG16BP to
G6P via βPGMP, occurring at a rate proportional to the amount of enzyme.
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19F chemical shifts are indistinguishable from those of the
βPGMWT:MgF3:G6P TSA complex (Supplementary Fig. 9e, f)
and a 1H15N-TROSY spectrum peak comparison (BMRB
723426) indicates an almost identical correspondence between
frequencies. Such close agreement allowed a backbone
resonance assignment (211 residues—100%) using 3D
HNCACB and 3D HN(CA)CO spectra (BMRB 28097).
Residues with the largest chemical shift differences between
the βPGMP146A:MgF3:G6P and βPGMWT:MgF3:G6P TSA
complexes are located within 4 Å of residue 146 (K145, A147
and A177) and within 5 Å of residue K145 (S48, V141 and
A142) (Supplementary Fig. 4d). Taken together, these results
confirm that βPGMP146A can assemble a stable and wild-type
like βPGMP146A:MgF3:G6P TSA complex in solution. The
βPGMP146A:MgF3:G6P TSA complex was crystallised and the
structure was determined to 1.0 Å resolution (PDB 6YDJ;
Supplementary Table 1). This complex superimposes very
closely with the βPGMWT:MgF3:G6P TSA complex (non-H
atom RMSD= 0.18 Å, PDB 2WF529) and identifies both the
positioning of the K145 sidechain in the active site and the cis
K145–A146 peptide bond (ω dihedral angle= 14°; compared
with ω dihedral angle= 12° for the K145–P146 peptide bond in
the βPGMWT:MgF3:G6P TSA complex) (Fig. 4b, d). The 6-
phosphate group of G6P is in the distal site and the trigonal
MgF3– moiety mimicking the transferring phosphoryl group is
coordinated in the proximal site between D8 (atom Oδ1) and
the 1-OH group of G6P. The donor–acceptor distance and the
angle of alignment are 4.1 Å and 174˚, respectively (compared
with 4.3 Å and 176°, respectively for the βPGMWT:MgF3:G6P
TSA complex). The catalytic Mg2+ ion coordination also has
comparable octahedral geometry to the βPGMWT:MgF3:G6P
TSA complex and to substrate-free βPGMP146A. Together,
these data demonstrate that βPGMP146A is able to populate a cis
K145–A146 peptide bond and achieve full domain closure with
concomitant formation of transition state geometry. In
addition, assuming that βG16BP binding is diffusion con-
trolled, the increase in Km for βG16BP in βPGMP146A reflects
the energetic cost of the trans to cis isomerisation of the
K145–A146 peptide bond46. As in βPGMWT, these results
imply that conformer A of βPGMP146A represents the more
active form.
βPGM forms two different transient phospho-enzyme species.
The possible involvement of conformer B in the modulation of
enzyme activity was investigated using real-time NMR methods
by comparing the phosphorylation of βPGM under saturating
conditions of either F16BP (50–100 mM), AcP (60–100 mM) or
βG16BP (35 mM). Residue A113 is a well-resolved reporter of the
relevant species—conformer A and conformer B, and their
phosphorylated counterparts, AP and BP. The carbonyl group of
A113 is coordinated by the ε-amino group of K145 (in conformer
A) or a water molecule (in conformer B) and its amide proton is
hydrogen bonded to the carbonyl group of F7 (adjacent to the D8
nucleophile) (Fig. 4a, b).
On addition of F16BP to βPGMP146A, the two dominant
species observed are conformer B and BP (Fig. 2b). The presence
of conformer B shows that the phosphorylation rate of
βPGMP146A is very similar to the dephosphorylation rate of BP
(through hydrolysis), and only an apparent rate constant can be
measured. The apparent rate constant for dephosphorylation was
determined to be 0.003 ± 0.00002 s−1 from the rate of reduction
of the free F16BP concentration in 1H NMR experiments. The 1H
and 15N chemical shifts of BP, assigned using fast acquisition 3D
HNCO and 3D HNCA NMR experiments, mirror those of
conformer B, except for the active site residues F7–D8,
A113–A115 and hinge residues T16–E18, owing to their
proximity to phosphorylated D8 (Supplementary Fig. 4e).
Resonances from the D137–A147 loop show no significant
differences between both forms, indicating that the K145–A146
peptide bond is in a trans conformation in BP (the conformer B to
AP transition results in large chemical shift changes for the
D137–A147 loop; Supplementary Fig. 4f). Conformer B and BP
are also observed when AcP was used as the phosphorylating
agent, and a minor population of AP is present, correlating with a
small increase in the population of BP relative to conformer B
(Supplementary Fig. 7b). Identification of AP is based on the
assignment and structure of the βPGMWT:BeF3 complex (BMRB
17851; PDB 2WFA35), where the K145–P146 peptide bond is in a
cis conformation and the K145 sidechain is engaged in the active
site. Notably, when βG16BP was used as the phosphorylating
agent, BP is not observed (Fig. 2b, Supplementary Fig. 7b).
Instead, the AP:G6P and B:βG16BP complexes are the primarily
populated species. The AP:G6P complex has similar chemical
shifts to the βPGMWT:BeF3 complex, and the slow exchange
between the B:βG16BP and the AP:G6P complexes correlates with
the measured kcat values for βPGMP146A.
In βPGMWT, AP is the dominant species observed on addition
of F16BP (Fig. 2a, Supplementary Fig. 3c). Therefore, the
phosphorylation rate of βPGMWT by F16BP under these
conditions must be faster than the hydrolysis rate of AP
(khydrolysis= 0.06 ± 0.006 s−1)31. A minor population of the
A:F16BP complex is also present, indicating that the phosphor-
ylation rate is slower than the chemical shift difference between
the AP and A:F16BP peaks (140 Hz). Significantly, a minor
population of BP is also observed. This species is populated
transiently (~5 min) and disappears at longer timeframes,
whereas AP and the A:F16BP complex populations remain
dominant while the phosphorylating agent is at high concentra-
tion. Hence, the BP population is converting to the more stable
AP species with a rate constant of ≥0.003 s−1, which mirrors the
trans to cis isomerisation rate constants of Xaa-Pro peptide bonds
in model peptides39. Equivalent behaviour is observed when AcP
was used as the phosphorylating agent (Supplementary Figs. 3b,
7a), except that an A:AcP complex is not detected. When βG16BP
was used as a phosphorylating agent, BP does not accumulate at
any point in the 3 h time course. The only detectable species is an
A:βG16BP complex (Fig. 2a, Supplementary Figs. 3d, 7a), which
is identified by the similarity of chemical shift distribution with
the βPGMD10N:βG16BP complex (BMRB 27174; PDB 5OK131).
The low intensity of the A113 peak, along with peaks of other
active site residues (Fig. 2a, Supplementary Figs. 3d, 7a), results
from millisecond conformational exchange between species
within the catalytic cycle, which correlates with the measured
kcat values for βPGMWT. Overall therefore, the consequence of
phosphorylation by the reaction intermediate βG16BP is
markedly different to that of other phosphorylating agents, in
that it generates no detectable BP or lag phase, even when the
initial population of conformer B is high.
Discussion
Substrate-free βPGMWT exists in solution as two distinct con-
formers with near-equal populations, which differ in the iso-
merisation state of the K145–P146 peptide bond and interconvert
at a rate between 0.003 s−1 and 1.0 s−1. Conformer A contains the
cis-isomer of this peptide bond, as observed in the crystal struc-
tures of substrate-free βPGMWT, whereas conformer B contains
the trans-isomer, as mimicked by the βPGMP146A variant. In the
crystal structure of βPGMP146A, the trans K145–A146 peptide
bond positions the sidechain of K145 away from the site of
phosphoryl transfer, which is significantly different to its location
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in all other substrate-free and TSA complex structures reported
for βPGMWT. The removal of this positively charged amine group
from the active site of conformer B disrupts the charge balance in
the vicinity of the D8 nucleophile and therefore transition state
stability will be severely impaired47,48. However, kinetics data for
the mutase reaction indicate that βPGMP146A is only ~20-fold less
active than βPGMWT, and has a similar affinity for βG1P. In the
crystal structure of the βPGMP146A:MgF3:G6P TSA complex,
which mimics the transition state of the phosphoryl transfer step,
the K145–A146 peptide bond adopts the cis-isomer and the
sidechain of K145 is able to engage in the active site. Hence,
conformer A remains the preferred route for phosphoryl transfer
in βPGMP146A, despite it being ~1000 times less stable than in
βPGMWT because of the trans to cis isomerisation of the
K145–A146 peptide bond46.
This disruption of the active site has regulatory significance, as
conformer B of βPGMWT constitutes a substantial population of
the resting substrate-free enzyme. In vitro, linear initial kinetics
and full activation of the enzyme are achieved only when βG16BP
is used as the phosphorylating agent. Phosphorylation of both
βPGMWT and βPGMP146A with either F16BP or AcP leads to a lag
phase, with the lag caused by F16BP lasting ~3.5 times longer
than that observed with AcP. Moreover, real-time NMR experi-
ments establish that the phosphorylation of both βPGMWT and
βPGMP146A with either F16BP or AcP result in the generation of
BP. In βPGMWT, BP isomerises completely into AP in <5 min,
whereas in βPGMP146A, BP is consistently more populated than
AP. In contrast, BP is not observed for either βPGMWT or
βPGMP146A when βG16BP is used as the phosphorylating agent.
This result demonstrates that phosphorylation with βG16BP leads
to the stabilisation of conformer A, resulting in production of AP,
regardless of the initial βPGM conformation, even for the
βPGMP146A variant despite the considerable energetic cost of the
conformer B to conformer A transition. Thus, conformer B and
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BP are significantly less-active forms of βPGM, and the slow
transition from BP to AP is part of the characteristic lag phase
observed in the coupled assay kinetics. The longer lag in the
F16BP experiments and the observation of a βPGMWT:F16BP
complex are consistent with F16BP having a slower phosphor-
ylation rate than AcP. Therefore, βPGM is able to follow alter-
native kinetic pathways depending on the phosphorylating agent
present, with its overall catalytic rate determined by the rate-
limiting step in each pathway (Fig. 6a, b).
The response of βPGM to different phosphorylating agents also
has functional significance. In L. lactis, the sole source of βG16BP
is βPGM itself. In contrast, F16BP accumulates during glycolysis,
reaching a concentration of up to ~50 mM17. Hence, F16BP is
likely to be the primary source of βPGM activation in vivo, with
AcP contributing to a lesser extent43,44. Correspondingly, a pro-
portion of βPGM will populate the less-active BP species. Fol-
lowing a switch from glucose to maltose or trehalose metabolism,
which will greatly increase the βG1P concentration (Supple-
mentary Fig. 1), βG16BP will begin to accumulate (Fig. 1, 6a, b).
As a result, the conformer B and BP populations will be recruited
into the more active AP species. This two-state control mechan-
ism allows L. lactis to effectively catabolise maltose or trehalose,
while the increase in transcription of pgmB is in progress20.
Furthermore, when carbohydrate levels are low, a significant
proportion of the basal βPGM population will be maintained as
conformer B, which will consequently reduce the undesirable
dephosphorylation of F16BP and also hinder the conversion of
G6P to βG1P.
The multi-second substrate-dependent non-allosteric con-
formational exchange mediated through cis–trans proline iso-
merisation seen in βPGM represents a mechanism of post-
translational enzyme regulation. This regulation mechanism relies
on the existence of alternative pathways with different rate-
limiting steps, where the catalytic rate depends on the capacity of
an activator, acting as a substrate, to bias the enzyme population
towards the fastest pathway, by stabilising the most active con-
formation (Fig. 7). Similar to allostery and allokairy, this
mechanism depends on the ability of the enzyme to adopt at least
two conformations with distinct activities, but does not require
the binding of an additional effector to the protein, nor an
equivalence between the conformational exchange rate and the
catalytic rate. We suggest the name allomorphy for this
mechanism, from the greek allos meaning other and morphe
meaning form, in keeping with the previously described allostery
and allokairy mechanisms15.
Allomorphy may modulate the activity of other monomeric
enzymes with hysteretic behaviour, i.e., those that exhibit a burst
or lag phase in their kinetic profile49. Several theoretical models
have been put forward to rationalise hysteretic behaviour, such as
the mnemonic50 and the ligand-induced slow transition51 mod-
els, but detailed structural-based molecular mechanisms have
proved elusive. To our knowledge, only one such mechanism,
allokairy in human glucokinase, has been described in detail15,16.
Allomorphy is a different fine control regulatory mechanism and
is potentially widespread, at least across phosphomutases; for
example, both rabbit muscle and L. lactis α-phosphoglucomutases
appear to be hysteretic enzymes52,53, but belong to very different
protein superfamilies. Like βPGM, these enzymes require a
phosphorylating agent to initiate the catalytic cycle and, for the
latter, the use of the reaction intermediate results in linear
kinetics, whereas alternative phosphorylating agents produce a lag
phase in their kinetic profiles. Similarly, α-phosphomannomutase
from Galdieria sulphuraria, which also requires the addition of a
phosphorylating agent to initiate the catalytic cycle, exhibits lin-
ear kinetics when α-mannose 1-phosphate and α-mannose 1,6-
bisphosphate (or α-glucose 1-phosphate and αG16BP) are
included in the reaction, but has a lag phase when there is a
mismatch between substrate and phosphorylating agent, or when
F16BP is used as the phosphorylating agent54. All of these
observations are consistent with the presence of allomorphic
control.
In summary, allomorphy is a fine control mechanism by which
part of an enzyme population is maintained in a more latent state,
and is quickly switchable between high and low activity levels,
without allosteric effectors. It delivers important control with
which L. lactis is able to reconcile two seemingly contradictory
requirements: the need to maximise its responsiveness to changes
in carbohydrate source and the need to minimise unproductive
diversion of valuable metabolites.
Methods
β-phosphoglucomutase (βPGM) expression and purification. Wild-type βPGM
(βPGMWT) and the P146A variant (βPGMP146A) proteins were expressed using
either 15N or 2H15N13C isotopic enrichment55 and purified using methodology
that minimised the presence of contaminating phosphoryl transfer enzymes (e.g.,
phosphoglucose isomerase and βPGM from E. coli)31,42. The βPGMWT and
βPGMP146A genes were cloned into the pET-22b(+) plasmid, transformed into E.
coli strain BL21(DE3) cells and expressed in defined isotopically labelled minimal
media. Cells were grown at 37 °C with shaking until OD600nm= 0.6, then cooled at
25 °C and induced with 0.5 mM isopropyl β-D-1-thiogalactopyranoside for a fur-
ther 18 h. Cells were harvested by centrifugation at 10,000 rpm for 10 min. The cell
pellet was resuspended in ice-cold lysis buffer (50 mMK+ HEPES (pH 7.2), 2 mM
NaN3, 1 mM EDTA) supplemented with cOmplete™ protease inhibitor cocktail and
lysed by six cycles of sonication. The cell lysate was cleared by centrifugation at
20,000 rpm for 35 min at 4 °C. The supernatant was filtered using a 0.22 µm syringe
filter and loaded onto a DEAE-Sepharose fast flow anion-exchange column. Pro-
teins bound to the column were eluted with a gradient of 0–50% lysis buffer
containing 1 M NaCl. Fractions containing βPGM were purified further using a
Hiload 26/600 Superdex 75 size-exclusion column previously equilibrated with lysis
buffer containing 1M NaCl. Final fractions were pooled, buffer exchanged into
50 mMK+ HEPES buffer (pH 7.2) containing 2 mM NaN3 and concentrated to
~1.6 mM for storage at −20 °C.
Reagents. Unless otherwise stated, reagents were purchased from Sigma-Aldrich,
GE Healthcare, Melford Laboratories or CortecNet. βG1P was synthesised enzy-
matically from maltose using maltose phosphorylase (EC 2.4.1.8)31. A solution of
maltose (600 mM) was incubated overnight with 1.2 units mL−1 maltose phos-
phorylase in 0.5 M sodium phosphate buffer (pH 7.0) at 30 °C and βG1P pro-
duction was confirmed using 31P NMR spectroscopy. Maltose phosphorylase was
removed using a Vivaspin (5 kDa MWCO) and the resulting flow-through was
used without further purification. βG16BP was produced enzymatically from βG1P
and AcP using the D170N variant of βPGM (βPGMD170N; expressed and purified
as detailed above)56. βG1P and AcP were incubated with βPGMD170N for 4 h at
25 °C and the reaction was quenched by heating at 90 °C for 10 min. βG16BP was
purified using barium salt precipitation.
NMR spectroscopy. 1H15N-TROSY NMR spectra of βPGMWT and βPGMP146A
were acquired at 298 K using 0.5–1 mM 15N-βPGM in standard NMR buffer (50
mMK+ HEPES (pH 7.2), 5 mM MgCl2, 2 mM NaN3 with 10% (v/v) 2H2O and 1
mM TSP). Typically, 1H15N-TROSY spectra were accumulations of 16 transients,
with 256 increments and spectral widths of 32–36 ppm centred at 120 ppm in the
indirect 15N dimension. 1H15N-TROSY-based ZZ-exchange experiments were
performed at mixing times of 100, 300, 500 and 900 ms. Rapid acquisition 1H15N
BEST-TROSY experiments to monitor the steady-state behaviour of 15N-βPGMWT
(0.2 mM) and 15N-βPGMP146A (0.2 mM) were acquired in standard kinetic buffer
(200 mMK+ HEPES (pH 7.2), 5 mM MgCl2, 2 mM NaN3 with 10% (v/v) 2H2O
and 1mM TSP) containing either 50–100 mM F16BP, 60–100 mM AcP or 35 mM
βG16BP. The 1H15N BEST-TROSY spectra were recorded at 298 K using a Bruker
600MHz Neo spectrometer equipped with a 5-mm TCI cryoprobe and z axis
gradients as 11 min experiments (16 transients, 128 increments and a recycle delay
of 0.2 s) with selective 1H pulses centred on the amide region (8.3 ppm). Excitation
pulses (90°) were 1.7 ms (pulse shape Eburp2), whereas refocusing pulses (180°)
were 1.4 ms (pulse shape Reburp). The experimental dead-time was ~5 min.
For βPGMP146A prepared in standard kinetic buffer containing 50 mM F16BP,
BP dephosphorylation was monitored at 298 K by consecutive one-dimensional 1H
NMR experiments recorded with 16 transients, a 1 s recycle delay and a spectral
width of 32 ppm centred on the water signal. Following 0.3 Hz Lorentzian
apodisation and baseline correction, normalised integral values of the F16BP peak
(4.22–4.15 ppm) were plotted against time to give a kinetic profile. The initial linear
steady-state portion of the kinetic profile was fitted using a linear least-squares
fitting algorithm included in MATLAB 2018a to derive an apparent
dephosphorylation rate constant.
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To observe the species present immediately following the addition of
phosphorylating agent to βPGMWT, NMR experiments were recorded with the use
of a homemade rapid mixing device. The equipment comprised a 2 m length of 0.8
mm internal diameter EFTE tubing (GE Healthcare), connected at one end to a 1
mL syringe and inserted at the other end through the lid of an NMR tube. The
tubing was loaded with phosphorylating agent (550 μL 100 mM F16BP or 250 μL
320 mM AcP, prepared in standard kinetic buffer) and a small, additional volume
of air was drawn in to prevent premature mixing of the phosphorylating agent with
the 550 μL 1.2 mM 15N-βPGMWT sample prepared in standard kinetic buffer. The
rapid mixing device was loaded into a Bruker 600MHz Neo spectrometer and
allowed to equilibrate thermally at 298 K. Following mixing by syringe action of the
phosphorylating agent (final concentration: 50 mM F16BP or 100 mM AcP) with
the βPGMWT sample, the spectrometer was locked (with ~7% (v/v) 2H2O), tuned
and shimmed, and the 1H 90° pulse length was calibrated. A series of 1H15N BEST-
TROSY spectra were recorded as 142 s experiments (4 transients, 128 increments
and a recycle delay of 0.15 s). The experimental dead-time was ~156 s.
Multi-dimensional heteronuclear NMR spectra for 1H, 15N and 13C backbone
resonance assignment of 2H15N13C-βPGMWT in standard NMR buffer containing
10 mM tris were acquired at 298 K on a Bruker 800MHz Avance III spectrometer
equipped with a 5-mm TCI cryoprobe and z axis gradients. The standard Bruker
suite of 1H15N-TROSY and 3D TROSY-based constant time experiments were
acquired (HNCO, HN(CA)CO, HNCA, HN(CO)CA, HNCACB, HN(CO)CACB)
using non-uniform sampling (NUS) with a multi-dimensional Poisson Gap
scheduling strategy with exponential weighting57. NUS data were reconstructed
using multi-dimensional decomposition in TopSpin358. Backbone resonance
assignments for conformer A and conformer B present simultaneously in the
spectra were obtained using a simulated annealing algorithm employed by the
asstools assignment program55 and assignments were confirmed using sequential
backbone amide to amide correlations obtained from TROSY-based (H)N(COCA)
NNH and H(NCOCA)NNH experiments59. Multi-dimensional heteronuclear
NMR spectra for 1H, 15N and 13C backbone resonance assignment of the
2H15N13C-βPGMP146A:MgF3:G6P TSA complex in standard NMR buffer
containing 15 mM NaF and 10 mM G6P were acquired at 298 K on a Bruker 800
MHz Avance I spectrometer equipped with a 5-mm TXI probe and z axis gradients.
1H15N-TROSY and 3D TROSY-based constant time experiments were acquired
(HN(CA)CO and HNCACB) and backbone resonance assignments were obtained
using asstools55. Multi-dimensional heteronuclear NMR spectra for 1H, 15N and
13C backbone resonance assignment of phosphorylated 2H15N13C-βPGMP146A in
standard kinetic buffer containing 75–100 mM F16BP were acquired at 298 K on a
Bruker 800MHz Neo spectrometer equipped with a 5-mm TXI probe and
z axis gradients. 1H15N-TROSY and 3D TROSY-based constant time experi-
ments were acquired (HNCO and HNCA) using NUS with a multi-dimensional
Poisson Gap scheduling strategy with exponential weighting57. NUS data were
reconstructed using multi-dimensional decomposition in TopSpin458. TROSY
resonances were assigned by comparing the correlated 13C chemical shifts
with those of βPGMP146A (BMRB 2792042) and the βPGMWT:BeF3 complex
(BMRB 1785135). Experiments were processed using TopSpin (Bruker) or
FELIX (Felix NMR, Inc.) and NMR figures were prepared using FELIX. 1H
chemical shifts were referenced relative to the internal TSP signal resonating
at 0.0 ppm, and 13C and 15N and chemical shifts were referenced indirectly using
nuclei-specific gyromagnetic ratios. Differences in chemical shift were calculated as:
∆δ= [(δHN-X–δHN-Y)2+ (0.12 × (δN-X–δN-Y))2]1/2, where X and Y are the two
species being compared.
Reaction kineltics for βPGMP146A-catalysed reactions were followed using a
Bruker 500MHz Avance DRX spectrometer (operating at 202.456MHz for 31P)
equipped with a room-temperature broadband probe. The equilibration of 10 mM
βG1P with G6P by 1–3 μM βPGMP146A was measured in standard kinetic buffer at
298 K. The reaction was initiated by and timed from the addition of 20 mM AcP
and monitored by the acquisition of consecutive 31P spectra without proton-
phosphorus decoupling with 256 transients and a 1 s recycle delay. A spectral width
of 50 ppm centred at −10 ppm enabled the observation of the relevant phosphorus
signals. Normalised integral values of both the βG1P and G6P peaks following
baseline correction and 5 Hz Lorentzian apodisation were plotted against time to
give kinetic profiles. The linear steady-state portion of the G6P integral data was
fitted using a linear least-squares fitting algorithm to derive the observed rate
constant, kobs.
One-dimensional 19F NMR experiments were acquired at 298 K on a Bruker
500MHz Avance III spectrometer (operating at 470.536MHz for 19F) equipped
with a 5-mm QCI-F cryoprobe and z axis gradients. Samples were prepared using
0.5 mM 15N-βPGMWT or 15N-βPGMP146A in standard NMR buffer (without 10%
(v/v) 2H2O) containing 15 mM NaF and 10 mM G6P. The spectrometer lock was
provided by 2H2O sealed inside a glass capillary tube inserted into the sample tube.
Typically, ~6000 transients were acquired without 1H decoupling over a spectral
width of 120 ppm and were processed with sinebell functions shifted by 60°.
For NMR experiments conducted in filtered milk, fresh skimmed bovine milk
purchased from a local supermarket was filtered using a 10 kDa MWCO Vivaspin
(Sartorius) to remove fat micelles and milk proteins. A 1 mM 15N-βPGMWT
sample prepared in standard NMR buffer was diluted fivefold with the resulting
milk flow-through and 10% (v/v) 2H2O and 1mM TSP were added to the sample.
Experiments were acquired at 298 K on a Bruker 800MHz Avance I spectrometer
equipped with a 5-mm TXI probe and z axis gradients. The pH of the sample was
estimated as pH 6.8 using the residual 1H resonances of HEPES buffer originating
from the standard NMR buffer.
For NMR experiments conducted in the absence of salt, a 1.4 mM
15N-βPGMWT sample in standard NMR buffer containing an additional 200 mM
NaCl was buffer-exchanged into freshly produced deionised water (18.2 MΩ.cm,
Purelab Classic, Elga-Veolia), with an equivalent dilution of the previous buffer by
a factor of 18.7 × 106. The resulting sample contained 0.9 mM βPGMWT at pH 6.3
and was supplemented with 10% (v/v) 2H2O for the deuterium lock. Experiments
were acquired at 298 K on a Bruker 800MHz Avance I spectrometer equipped with
a 5-mm TXI probe and z axis gradients.
Kinetic experiments using coupled assays. All kinetic assays for βPGMWT and
βPGMP146A were conducted at 298 K using a FLUOstar OMEGA microplate reader
and the BMG LABTECH Reader Control Software (version 5.11) (BMG Labtech) in
standard kinetic buffer (200mMK+ HEPES (pH 7.2), 5 mM MgCl2, 1 mM NaN3)
in a 160 μL reaction volume. The rate of G6P production was measured indirectly
using a glucose 6-phosphate dehydrogenase (G6PDH) coupled assay, in which G6P
is oxidised and concomitant NAD+ reduction is monitored by the increase in
absorbance at 340 nm (NADH extinction coefficient= 6220M−1 cm−1). βPGMWT
and βPGMP146A concentrations were determined using a NanoDrop OneC spec-
trophotometer (Thermo Scientific) and diluted accordingly (βPGM extinction
coefficient= 19,940M−1 cm−1). For the determination of kcat and Km values for
βPGMWT, the reaction was initiated by dilution of the enzyme prepared in standard
kinetic buffer to a final concentration of 1 nM βPGMWT in solutions of 1 mM
NAD+ and 5 units mL−1 G6PDH and variable concentrations of βG1P (10, 20, 30,
50, 70, 100, 150, 200, 300, 500, 700 µM) and βG16BP (0.4, 1, 2, 5, 10 µM). For the
determination of kcat and Km values for βPGMP146A, the reaction was initiated by
dilution of the enzyme prepared in standard kinetic buffer to a final concentration
of 100 nM βPGMP146A in solutions of 1 mM NAD+ and 5 units mL−1 G6PDH and
variable concentrations of βG1P (5, 10, 15, 20, 30, 50, 70, 100, 200, 300, 500 µM)
and βG16BP (2, 5, 10, 35, 50, 100 µM). The initial rate of G6P production was fitted
using a linear least-squares fitting algorithm to determine the reaction velocity (v0)
at each βG1P and βG16BP concentration at a total enzyme concentration (ET).
Mean data from triplicate measurements were subsequently globally fitted to
Eq. 128, which is derived for a ping–pong mechanism and adapted to account for
βG1P inhibition (Ki) to calculate kcat and individual Km values (KβG1P and KβG16BP),
with their corresponding standard deviations, using an in-house python non-linear
least-squares fitting program.
v0 ¼
kcat ET½  βG1P½  βG16BP½ 
βG1P½  βG16BP½  þ KβG1P βG16BP½  þ KβG16BP βG1P½ 
Kiþ βG1P½ 
Ki
  ð1Þ
Kinetic experiments demonstrating the effect of different phosphorylating
agents were conducted by the addition of either 5 nM βPGMWT or 200 nM
βPGMP146A to solutions containing either 1 mM F16BP, 8 mM AcP or 10 μM
βG16BP, together with 1 mM NAD+, 5 units mL−1 G6PDH and 50 μM βG1P.
F16BP represents an equilibrium mixture of an α-anomer (15%), a β-anomer (81%)
and two open chain forms with an interconversion rate of 8 s−1 60.
X-ray crystallography. For the crystallisation experiments of βPGMWT,
βPGMP146A, the βPGMP146A:MgF3:G6P TSA complex and the βPGMWT:citrate
complex, frozen aliquots of βPGMWT or βPGMP146A in standard native buffer (50
mMK+ HEPES (pH 7.2), 5 mM MgCl2, 2 mM NaN3) were thawed on ice and
centrifuged briefly to pellet insoluble material. For the βPGMP146A:MgF3:G6P TSA
complex, 15 mM NaF and 10 mM G6P were added to the βPGMP146A sample,
whereas for the βPGMWT:citrate complex, 50 mM citrate was added to the
βPGMWT sample. Solutions were adjusted to a final protein concentration of
0.4–0.6 mM, incubated for 1 h and mixed 1:1 with precipitant (24–34% (w/v) PEG
4000, 200 mM sodium acetate and 100 mM tris-HCl (pH 7.5)). Crystals were
grown at 290 K by hanging-drop vapour diffusion using a 2 μl drop suspended on a
siliconised glass cover slip above a 700 μL well. Rod-shaped or large plate crystals
grew typically over several days. Crystals were harvested using a mounted Litho-
Loop (Molecular Dimensions Ltd) and were cryo-protected in their mother liquor
containing an additional 25% (v/v) ethylene glycol (and 50 mM citrate for the
βPGMWT:citrate crystals) prior to plunging into liquid nitrogen. Diffraction data
were collected at 100 K on the MX beamlines at the Diamond Light Source (DLS),
Oxfordshire, United Kingdom.
Data were processed using the xia2 pipeline61 and resolution cutoffs were
applied using CC-half values and Aimless62. The crystals diffracted in the P212121
spacegroup, with cell dimensions that varied depending on the degree of enzyme
closure. Structures were determined by molecular replacement with MolRep
(version 11)63 using the highest resolution model with the most appropriate cap
and core domain relationship as a search model. Model building was carried out in
COOT (version 0.8.8)64 with ligands not included until the final rounds of
refinement with REFMAC565 so that they could be built into unbiased difference
Fourier maps. The βPGMP146A:MgF3:G6P TSA complex structure was refined with
anisotropic B-factors, whereas both the βPGMWT structures and the substrate-free
βPGMP146A structure were refined isotropically. Structure validation was carried
out in COOT and MolProbity (version 4.4)66. Superpositions and crystallographic
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figures were prepared using PyMOL (The PyMOL Molecular Graphics System,
version 1.8, Schrödinger, LLC). To confirm the isomerisation state of the
K145–A146 peptide bond in the structures of substrate-free βPGMP146A and the
βPGMP146A:MgF3:G6P TSA complex, difference density maps (Fo–Fc) were
generated using REFMAC5 with the S144–P148 segment omitted from the final
structures. Omit map figures were prepared using CCP4mg (version 2.10.9)67.
Additional details for X-ray crystallography data collection, data processing and
refinement are provided in Supplementary Table 1.
Data availability
Data supporting the findings of this manuscript are available from the corresponding
author upon reasonable request. The atomic coordinates and structure factors have been
deposited in the Protein Data Bank (www.rcsb.org) with the following codes:
βPGMWT:citrate complex (PDB 6YDM), substrate-free βPGMWT (PDB 6YDL),
substrate-free βPGMP146A (PDB 6YDK) and βPGMP146A:MgF3:G6P TSA complex (PDB
6YDJ). The NMR chemical shifts have been deposited in the BioMagResBank (www.
bmrb.wisc.edu) with the following accession numbers: substrate-free βPGMWT
conformer A (BMRB 28095), substrate-free βPGMWT conformer B (BMRB 28096) and
βPGMP146A:MgF3:G6P TSA complex (BMRB 28097).
Code availability
Code developed in Python3 and bash for this study is publicly available under an MIT
license and can be found on GitHub [https://doi.org/10.5281/zenodo.4022248].
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